Find all School-related info fast with the new School-Specific MBA Forum

It is currently 22 Sep 2014, 06:23

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

A manufacturer of anti-inflammatory medicine for infants

  Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:
Director
Director
User avatar
Joined: 16 Jun 2004
Posts: 893
Followers: 1

Kudos [?]: 9 [0], given: 0

GMAT Tests User
A manufacturer of anti-inflammatory medicine for infants [#permalink] New post 05 Dec 2004, 05:28
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

0% (00:00) correct 0% (00:00) wrong based on 0 sessions
A manufacturer of anti-inflammatory medicine for infants recently discovered that a batch of its medicine still in production contained improper and potentially harmful quantities of certain compounds. The manufacturer immediately issued a recall of all recently shipped batches, but some executives went on to propose that all remaining batches be destroyed as well, even though it would cost the company millions of dollars in lost revenue.

The proposal to destroy the remaining batches of medicine depends on which of the following assumptions?


A. The company will be able to recoup any lost revenue through sales of other medicines.
B. It cannot feasibly be determined whether the remaining batches of medicine are salable.
C. The public will not be aware of the destruction of the remaining medicine.
D. Destruction of the remaining batches would ensure that improper quantities of the compound are not present in any of the company's products.
E. Some of the remaining batches of medicine do not contain harmful quantities of the compound in question.
Director
Director
avatar
Joined: 29 Oct 2004
Posts: 865
Followers: 2

Kudos [?]: 38 [0], given: 0

GMAT Tests User
 [#permalink] New post 05 Dec 2004, 11:55
(D) as well
But if the OA is (E), I am not surprised.
Director
Director
User avatar
Joined: 16 Jun 2004
Posts: 893
Followers: 1

Kudos [?]: 9 [0], given: 0

GMAT Tests User
 [#permalink] New post 06 Dec 2004, 06:38
OA is B.
Director
Director
User avatar
Joined: 07 Nov 2004
Posts: 697
Followers: 4

Kudos [?]: 15 [0], given: 0

GMAT Tests User
 [#permalink] New post 06 Dec 2004, 06:48
Can someone explain why it is B? :(
Intern
Intern
avatar
Joined: 26 Nov 2004
Posts: 48
Followers: 1

Kudos [?]: 0 [0], given: 0

 [#permalink] New post 06 Dec 2004, 11:02
gayathri wrote:
Can someone explain why it is B? :(


gayathri,
Let me try, the proposal to destroy all the other batches would insure that there is no chance that any other children would get affected by this faulty medicine, that is what the proposal is trying to acheive. To acheive this goal the manufacturer is assuming that there is no other way to test them, if this not true then they could test the rest of the batches and didn't have to go by the proposal. I hope it makes some sense.
Director
Director
avatar
Joined: 03 Nov 2004
Posts: 870
Followers: 1

Kudos [?]: 8 [0], given: 0

GMAT Tests User
 [#permalink] New post 06 Dec 2004, 11:21
‘D’ is too extreme to assume that improper quantities of the compound are not present in any of the company's products.
Manager
Manager
avatar
Joined: 18 Jun 2004
Posts: 105
Location: san jose , CA
Followers: 1

Kudos [?]: 15 [0], given: 0

GMAT Tests User
 [#permalink] New post 06 Dec 2004, 11:55
A. The company will be able to recoup any lost revenue through sales of other medicines.

Company is not worried about sales nor revenues , eliminate A

B. It cannot feasibly be determined whether the remaining batches of medicine are salable.

If company can determine which batch has faulty medicine it can destroy only that batch but since company cannot pinpoint the problematic batch and it doesn't know which batch can be sold .

B is a proper answer for this


C. The public will not be aware of the destruction of the remaining medicine. - out of scope
D. Destruction of the remaining batches would ensure that improper quantities of the compound are not present in any of the company's products.
- some of the batches might be good in this so there is no need to destroy all of them .
E. Some of the remaining batches of medicine do not contain harmful quantities of the compound in question. - out of scope
_________________

---- Hero never chooses Destiny
Destiny chooses Him ......

  [#permalink] 06 Dec 2004, 11:55
    Similar topics Author Replies Last post
Similar
Topics:
Infants and Colors AkshayChittoria 5 25 Aug 2013, 23:41
1 Top Ten Tips for GMAT INFANTS Dreaming 6 07 Feb 2012, 23:11
It is probably not true that colic in infants is caused by gmatavenue 9 18 Apr 2009, 14:14
2 mother-infant bond Nihit 11 16 Sep 2008, 02:55
The average normal infant born in the United States weights mono 4 23 Jan 2007, 01:41
Display posts from previous: Sort by

A manufacturer of anti-inflammatory medicine for infants

  Question banks Downloads My Bookmarks Reviews Important topics  


GMAT Club MBA Forum Home| About| Privacy Policy| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.